ESMO/ECCO Presidential Session III
NO16968: XELOXA Adjuvant Treatment with Capecitabine and Oxaliplatin (XELOX) in Stage III Colon Cancer. ESMO/ECCO Presidential Session III D. Haller, J. Tabernero, J. Maroun, F. de Braud, T. Price, E. Van Cutsem, M. Hill, F. Gilberg, K. Rittweger, H.-J. Schmoll. Rationale for XELOXA trial.
480 views • 21 slides